Transforming cannabis plant
for medical purposes
Cannprisma-pharma is a 100% Portuguese company founded in 2018, which is dedicated to growing, processing, and transforming the cannabis plant for medical purposes. Cannprisma develops its activity along the entire value chain, with a Seed-to-sale structure that provides solutions for Growers, pharmaceutical wholesalers, pharmaceutical manufacturers and for Researchers.
Vision
To be a worldwide reference in the Medical Cannabis industry for our Ethics, Quality, Innovation and Safety inherent to the solutions we provide for the pharmaceutical industry.
Mission
Changing the “prism” from which society looks to Cannabis, through our products and services. To mitigate stigma and show to the public the benefits of using cannabis-based medicines as a treatment for specific medical conditions, and in symptoms management and relief.
Making available to the market products and raw materials that contribute to improving the welfare of patients around the world, respecting the highest standards of quality, safety, environmental sustainability, and social responsibility.
Our Values
Cannprisma spirit is based on health, transparency, and rigor. Our values include Ethics, Social and Environmental Responsibility, Safety, Quality, and Innovation.
Ethics
The Cannprisma code of ethical conduct is the foundation of any activity carried out by our employees.
Health
Is fundamental to us. We understand the needs of all those who can benefit from the use of cannabis-based medicines due to their health condition. Therefore, all the raw materials and products we develop aim to serve as tools to improve the well-being and quality of life of patients worldwide. Our goal is to dignify and facilitate access to the use of cannabis-based medicines.
Innovation
Within our team of young minds and open spirits, the desire to innovate to continuously improve our procedures, raw materials, products, and services is present. This is achieved through research projects and the establishment of institutional partnerships.
Environmental Sustainability
Taking care of people while simultaneously caring for the planet is one of Cannprisma’s main focuses. We invest in renewable energies to enhance our activities and incorporate mechanical processes into our cultivation, production, and transformation to give back to nature what it provides us.
Transparency
Our team performs their functions with maximum transparency. Beyond business relationships, we establish relationships of trust with our partners.
Safety
The Cannprisma entity operates under a meticulous security policy, covering our facilities, products, provided services, and activities.
Quality & Rigor
This is a mandatory factor in our raw materials, work methodologies, designed products, and provided services.
This is an indispensable pillar of our activity within the medicinal cannabis industry. Ensuring scientific rigor at all stages of the process is essential to ensure that the final product or provided service is worthy of its intended purpose in the pharmaceutical industry.
Social Responsibility
The purpose of our products and products conceived through the services we provide is of great importance and tremendous responsibility. That’s why our team is vertically concerned, aware, and socially responsible, as we recognize that the activities we carry out in the industry play a crucial role in the quality, safety, and effectiveness of cannabis-based medicines available to patients worldwide.
Our Team
We have an experienced and multidisciplinary team, which works with the commitment to do their best to make high quality products, services, and raw materials available to the market with the aim of improving the health and welfare of patients around the world. Get to know some of the forces that move us.
João Nascimento
CEO & Founder
Paulo Nascimento
Executive Partner
Elsa Nascimento
Executive Partner
Fernando Águas
Qualified Person & Industrial Director
Rui Soares
VP of International Sales & Marketing
José Real
Marketing Manager & Product Developer
Rui Dias
U-GMP Post-Harvest Manager
Marcelo Melo
Head of R&D & Extraction Unit
Zaida Giná
Quality Assurance Director
Maura Ferreira
Quality Control Manager
Our Process
Cannabis flower production
from cultivation to delivering
Our Facilities
Cannprisma, with its Seed-to-sale structure, bridges two different sectors, the agricultural sector related to the cultivation of Cannabis and the pharmaceutical sector inherent to the processing and transformation of the plant.
To better respond to the needs of the industry, the company’s operations take place in two different units, the cultivation unit and the industrial unit.
Our Journey
-
Cannprisma Establishment
October 2018
-
Start of the Manufacturing
Unit constructionDecember 2020
-
Obtaining the License to Grow
Cannabis for Medical Purposes (GACP)August 2021
-
Inauguration of the Cultivation Unit
September 2021
-
CUMCS Certification
November 2021
-
Start of the Cultivation Unit Expansion
June 2022
-
License to Manufacture Cannabis Medicines, Preparations and Substances for Medicinal Purposes (EU-GMP Part I)
February 2023
-
License to Manufacture Active
Substances (EU-GMP Part II)February 2023
-
Certification of the Quality Control Laboratories
July 2024
-
License for Wholesale Distribution (GDP)
2024
Cannprisma Products
Medical Cannabis Solutions
News & State of Art
Follow the company and industry.
Stay up to date with news from the company and the medical cannabis industry, subscribe to our newsletter and follow what we do for the industry, patients, and science!